J. Argente, L.A. Perez-Jurado, Genetic causes of proportionate short stature. Best. Pract. Res. Clin. Endocrinol. Metab. 32(4), 499–522 (2018). https://doi.org/10.1016/j.beem.2018.05.012.

Article  CAS  PubMed  Google Scholar 

C. Hage, H.W. Gan, A. Ibba, G. Patti, M. Dattani, S. Loche et al., Advances in differential diagnosis and management of growth hormone deficiency in children. Nat. Rev. Endocrinol. 17(10), 608–624 (2021). https://doi.org/10.1038/s41574-021-00539-5.

Article  PubMed  Google Scholar 

G.R. Society, Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH research society1. J. Clin. Endocrinol. Metab. 85(11), 3990–3993 (2000). https://doi.org/10.1210/jcem.85.11.6984.

Article  Google Scholar 

A.M. Procter, J.A. Phillips III, D.N. Cooper, The molecular genetics of growth hormone deficiency. Hum. Genet. 103(3), 255–272 (1998). https://doi.org/10.1007/s004390050815.

Article  CAS  PubMed  Google Scholar 

K.S. Alatzoglou, M.T. Dattani, Genetic causes and treatment of isolated growth hormone deficiency-an update. Nat. Rev. Endocrinol. 6(10), 562–576 (2010). https://doi.org/10.1038/nrendo.2010.147.

Article  CAS  PubMed  Google Scholar 

Q. Fang, A.F. Benedetti, Q. Ma, L. Gregory, J.Z. Li, M. Dattani et al., HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype. Clin. Endocrinol. 85(3), 408–414 (2016). https://doi.org/10.1111/cen.13067.

Article  CAS  Google Scholar 

L.C. de Graaff, J. Argente, D.C. Veenma, M.L. Drent, A.G. Uitterlinden, A.C. Hokken-Koelega, PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3+1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency. Horm. Res. Paediatr. 73(5), 363–371 (2010). https://doi.org/10.1159/000308169.

Article  CAS  PubMed  Google Scholar 

P.Q. Thomas, B.V. Johnson, J. Rathjen, P.D. Rathjen, Sequence, genomic organization, and expression ofthe novel homeobox gene Hesx1 (*). J. Biol. Chem. 270(8), 3869–3875 (1995).https://doi.org/10.1074/jbc.270.8.3869

T. Tajima, T. Hattorri, T. Nakajima, K. Okuhara, K. Sato, S. Abe et al., Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. J. Clin. Endocrinol. Metab. 88(1), 45–50 (2003). https://doi.org/10.1210/jc.2002-020818.

Article  CAS  PubMed  Google Scholar 

J.S. Dasen, J.P. Martinez Barbera, T.S. Herman, S.O. Connell, L. Olson, B. Ju et al., Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes. Dev. 15(23), 3193–3207 (2001). https://doi.org/10.1101/gad.932601.

Article  CAS  PubMed  PubMed Central  Google Scholar 

S. Pozzi, W.H. Tan, J. Martinez-Barbera, Characterization of a novel HESX1 mutation in a pediatric case of septo-optic dysplasia. Clin. Case Rep. 5(4), 463–470 (2017). https://doi.org/10.1002/ccr3.868.

Article  PubMed  PubMed Central  Google Scholar 

M.W. Sornson, W. Wu, J.S. Dasen, S.E. Flynn, D.J. Norman, S.M. O’Connell et al., Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384(6607), 327–333 (1996). https://doi.org/10.1038/384327a0.

Article  CAS  PubMed  Google Scholar 

M.J. McCabe, K.S. Alatzoglou, M.T. Dattani, Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond. Best. Pract. Res. Clin. Endocrinol. Metab. 25(1), 115–124 (2011). https://doi.org/10.1016/j.beem.2010.06.008.

Article  CAS  PubMed  Google Scholar 

A. Mehta, P.C. Hindmarsh, H. Mehta, J.P. Turton, I. Russell-Eggitt, D. Taylor et al., Congenital hypopituitarism: clinical, molecular and neuroradiological correlates. Clin. Endocrinol. 71(3), 376–382 (2009). https://doi.org/10.1111/j.1365-2265.2009.03572.x.

Article  Google Scholar 

K. Nykamp, M. Anderson, M. Powers, J. Garcia, B. Herrera, Y.Y. Ho et al., Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet. Med. 19(10), 1105–1117 (2017). https://doi.org/10.1038/gim.2017.37.

Article  PubMed  PubMed Central  Google Scholar 

C.C. Wang, H. Peng, Z. Wang, J. Yang, R.G. Hu, C.Y. Li et al., TRIM72-mediated degradation of the short form of p62/SQSTM1 rheostatically controls selective autophagy in human cells. Mil. Med. Res. 9(1), 35 (2022). https://doi.org/10.1186/s40779-022-00392-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Y. Yang, Y. Luo, C. Yang, R. Hu, X. Qin, C. Li, TRIM25-mediated ubiquitination of G3BP1 regulates the proliferation and migration of human neuroblastoma cells. Biochim. Biophys. Acta Gene Regul. Mech. 1866(3), 194954 (2023). https://doi.org/10.1016/j.bbagrm.2023.194954.

Article  CAS  PubMed  Google Scholar 

Y. Tao, X. Ding, C. Jia, C. Wang, C. Li, Using protein turnover assay to explore the drug mechanism of Carfilzomib. Acta Biochim. Biophys. Sin. 57(2), 209–222 (2024). https://doi.org/10.3724/abbs.2024104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

W. Hu, X. Qiu, Y. Yang, Y. Wu, C. Wang, R. Hu et al., A TRIM21-based method for targeted protein degradation. Acta Biochim. Biophys. Sin. 57(4), 667–670 (2024). https://doi.org/10.3724/abbs.2024179.

Article  PubMed  PubMed Central  Google Scholar 

J. Abramson, J. Adler, J. Dunger, R. Evans, T. Green, A. Pritzel et al., Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024). https://doi.org/10.1038/s41586-024-07487-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

A.D. Kardelen Al, S. Poyrazoglu, A. Aslanger, G. Yesil, S. Ceylaner, F. Bas et al., A rare cause of adrenal insufficiency - isolated ACTH deficiency due to TBX19 mutation: long-term follow-up of two cases and review of the literature. Horm. Res. Paediatr. 92(6), 395–403 (2019). https://doi.org/10.1159/000506740.

Article  CAS  PubMed  Google Scholar 

L.R. Carvalho, K.S. Woods, B.B. Mendonca, N. Marcal, A.L. Zamparini, S. Stifani et al., A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. J. Clin. Invest. 112(8), 1192–1201 (2003). https://doi.org/10.1172/jci18589.

Article  CAS  PubMed  PubMed Central  Google Scholar 

D. Khandelwal, N. Tandon, Overt and subclinical hypothyroidism. Drugs 72(1), 17–33 (2012). https://doi.org/10.2165/11598070-000000000-00000.

Article  CAS  PubMed  Google Scholar 

M. Avbelj Stefanija, P. Kotnik, N. Bratanic, M. Zerjav Tansek, S. Bertok, N. Bratina et al., Novel mutations in HESX1 and PROP1 genes in combined pituitary hormone deficiency. Horm. Res. Paediatr. 84(3), 153–158 (2015). https://doi.org/10.1159/000433468.

Article  CAS  PubMed  Google Scholar 

B. Cheng, J. Zhu, T. Yang, S. Wang, H. Liu, Q. Wu et al., Vitamin A deficiency exacerbates autism-like behaviors and abnormalities of the enteric nervous system in a valproic acid-induced rat model of autism. Neurotoxicology 79, 184–190 (2020). https://doi.org/10.1016/j.neuro.2020.06.004.

Article  CAS  PubMed  Google Scholar 

A. Mann, A. Aghababaie, J. Kalitsi, D. Martins, Y. Paloyelis, R.R. Kapoor, Neurodevelopmental impairments in children with septo-optic dysplasia spectrum conditions: a systematic review. Mol. Autism 14(1), 26 (2023). https://doi.org/10.1186/s13229-023-00559-0.

Article  PubMed  PubMed Central  Google Scholar 

X. Jiang, X. Chen, J. Su, N. Liu, Prevalence of autism spectrum disorder in mainland china over the past 6 years: a systematic review and meta-analysis. BMC Psychiatry 24(1), 404 (2024). https://doi.org/10.1186/s12888-024-05729-9.

Article  PubMed  PubMed Central  Google Scholar 

M.T. Dattani, J.-P. Martinez-Barbera, P.Q. Thomas, J.M. Brickman, R. Gupta, I.-L. Mårtensson et al., Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat. Genet. 19(2), 125–133 (1998). https://doi.org/10.1038/477.

Article  CAS  PubMed